Schizophrenia and obesity: May the gut microbiota serve as a link for the pathogenesis?
iMeta · 2023-05 · 2 (2)
DOI: 10.1002/imt2.99 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift iMeta, online erschienen am 04.04.2023. Verfasst von Hui Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry Department Third Affiliated Hospital of Sun Yat-sen University Guangzhou China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Schizophrenia (SZ) places a tremendous burden on public health as one of the leading causes of disability and death. SZ patients are more prone to developing obesity than the general population from the clinical practice. The development of obesity frequently causes poor psychiatric outcomes in SZ patients. In turn, maternal obesity during pregnancy has been associated with an increased risk of SZ in offspring, suggesting that these two disorders may have shared neuropathological mechanisms. The gut microbiota is well known to serve as a major regulator of bidirectional interactions between the central nervous system and the gastrointestinal tract. It also plays a critical role in maintaining physical and mental health in humans. Recent studies have shown that the dysbiosis of gut microbiota is intimately associated with the onset of SZ and obesity through shared pathophysiological mechanisms, particularly the stimulation of immune inflammation. Therefore, gut microbiota may serve as a common biological basis for the etiology in both SZ and obesity, and the perturbed gut–brain axis may therefore account for the high prevalence of obesity in patients with SZ. On the basis of these findings, this review provides updated perspectives and intervention approaches on the etiology, prevention, and management of obesity in SZ patients by summarizing the recent findings on the role of gut microbiota in the pathogenesis of SZ and obesity, highlighting the role of gut‐derived inflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Psychiatry Department Third Affiliated Hospital of Sun Yat-sen University Guangzhou China.
- State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Institute of Microbiology Guangdong Academy of Sciences Guangzhou China.
- Department of Life Sciences Imperial College London London United Kingdom.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Wu, H., Liu, Y., Wang, J., Chen, S., Xie, L., & Wu, X. (2023). Schizophrenia and obesity: May the gut microbiota serve as a link for the pathogenesis?. iMeta, 2(2). https://doi.org/10.1002/imt2.99
Vancouver
Wu H, Liu Y, Wang J, Chen S, Xie L, Wu X. Schizophrenia and obesity: May the gut microbiota serve as a link for the pathogenesis?. iMeta. 2023;2(2). doi:10.1002/imt2.99
BibTeX
@article{Wu2023,
author = {Wu, Hui and Liu, Yaxi and Wang, Jie and Chen, Shengyun and Xie, Liwei and Wu, Xiaoli},
title = {Schizophrenia and obesity: May the gut microbiota serve as a link for the pathogenesis?},
journal = {iMeta},
year = {2023},
volume = {2},
number = {2},
doi = {10.1002/imt2.99}
}
EUVIMED